RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 70 filers reported holding RA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $610,000 | -22.5% | 27,224 | -37.0% | 0.01% | -20.0% |
Q4 2018 | $787,000 | +0.6% | 43,224 | 0.0% | 0.01% | +25.0% |
Q3 2018 | $782,000 | +91.7% | 43,224 | +5.4% | 0.01% | +100.0% |
Q2 2018 | $408,000 | +87.2% | 41,000 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $218,000 | – | 41,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |